DOCU

ANALYST NOTE: DOCU (DocuSign, Inc.) Date: 2026-06-13 Current Price: $43.47

1. Structural Readiness

State: Context-Only Conservative Entry: — Breakout Level: — Extension: — ATR Current: 5.6% (High)

Structural Assessment:

2. Thesis Layer

Thesis Classification: Tactical / Setup-Led Secular Thesis: None Named

At this date, DOCU is classified as a Tactical, setup-led name. There is no named macro or secular thesis driving the immediate conviction stack. The investment case must be judged strictly on the quality of the business fundamentals (as evidenced by the earnings transcripts and filings) and the eventual formation of a technical structure. We do not invent a thesis; we observe that the company is executing a transition toward an AI-native platform, but the market has not yet priced this into a confirmed structural breakout. The conviction weight rests entirely on the strength of the operational metrics provided in the evidence block and the future resolution of the price structure.

3. Business Analysis

Company Overview: DocuSign, Inc. is a global provider of electronic signature software and digital agreement management solutions. The company operates within the Technology sector, specifically in the software industry. Its core offerings include the AI-native Identity, Agreement, and Management (IAM) platform, the world's leading e-signature solution, and Contract Lifecycle Management (CLM).

Business Model & Evidence: The company generates substantially all revenue from subscription sales (98% of revenue in FY2026), creating a high-recurring revenue base.

• Growth & Guidance: In the earnings transcript dated 2026-06-04, management stated they expect year-over-year growth to be between 8.25% and 8.75%, targeting over $3.5 billion in revenue at the midpoint for the end of Q4 Fiscal 2027.
• Product Mix (IAM): The IAM platform is a key growth driver. As of the Q1 2027 period (ended April 30, 2026), IAM represented 12.6% of total ARR, up from 10.8% in the prior quarter. Management expects IAM to reach approximately 18% of total ARR by the end of Q4 Fiscal 2027, driving IAM ARR to over $600 million.
• Customer Expansion: The number of customers with greater than $300,000 in annualized contract value increased to 1,258 as of April 30, 2026, from 1,123 a year prior.
• International Growth: International revenue grew 17% in the three months ended April 30, 2026, representing 31% of total revenue, up from 28% the prior year.
• Profitability: Management expects non-GAAP operating margins to reach 29.7% to 30.2% for Q2 and 30.5% to 31.0% for Fiscal 2027, an increase of 0.5% at the midpoint versus prior guidance.
• Cash Flow: Operating cash flow was $321.7 million in the three months ended April 30, 2026.
• Competitive Landscape: The primary global competitor for eSignature is Adobe (Adobe Acrobat Sign). DocuSign differentiates via its AI-native IAM platform, which a Deloitte study cited in the transcript claims yields a nearly 30% increase in ROI compared to 3% for AI point products.

4. Archetype and Conviction

Archetype: Quality Compounder Rationale: The company fits the Quality Compounder archetype based on the following factors observed as of 2026-06-13:

• Margin Inflector: Management guidance indicates a clear path to expanding non-GAAP operating margins to the 30%+ range, driven by the higher-margin IAM product mix and operating leverage.
• Recurring Revenue Quality: With 98% of revenue from subscriptions and a diverse customer base (no single customer >10% of revenue), the business model exhibits high stickiness and predictability.
• Structural Growth: The shift from a pure e-signature vendor to an AI-native agreement platform (IAM) is evidenced by the rapid growth in IAM ARR share (10.8% to 12.6% in one quarter) and the strategic partnerships (e.g., Experian, HSBC) to embed IAM into broader workflows.
• Valuation Context: The financial spine indicates forward consensus EPS of $3.79 for FY1 and $4.51 for FY2. While the current price of $43.47 implies a forward P/E of approximately 11.5x (FY1) and 9.6x (FY2), the structural quality of the business (high margins, high growth in a strategic segment) suggests the market may be pricing in a "value" or "turnaround" narrative rather than a pure "growth" narrative.

Conviction Stack:

• Thesis Strength: Moderate (Tactical, no macro thesis).
• Evidence Quality: High (Detailed guidance, specific ARR metrics, clear margin targets).
• Structural Quality: Low/Unknown (No defined setup).
• Setup Readiness: None (Context-only).
• Rerating Potential: Dependent on the confirmation of the "Quality Compounder" narrative through a technical breakout, which is currently absent.

5. Invalidations, Strengths, and Gaps

What Would Strengthen the Case:

• Accelerated IAM Adoption: Evidence that IAM ARR growth accelerates beyond the 18% target or that the 10x ROI claim translates to faster enterprise adoption rates.
• Margin Beat: Management raising the FY2027 margin guidance above the 31.0% midpoint.

What Would Invalidate the Case:

• Growth Deceleration: A miss on the 8.25%-8.75% growth guidance or a decline in the number of large enterprise customers (> $300k ACV).
• Margin Compression: Failure to achieve the 30%+ non-GAAP operating margin target.

Gaps in Evidence:

• Specific Entry/Stop Data: No conservative entry price or specific stop-loss level is available in the current data set.
• ATR at Breakout: The ATR at the moment of a potential breakout is unknown, limiting the ability to size the trade based on structural quality.

PRIVATE ANALYST CALL

Judgment: Hold Confidence: medium Key evidence: Management guidance for 8.5% YoY growth and 30.5-31.0% operating margins; IAM ARR growing to 12.6% of total ARR with clear path to 18%; strong operating cash flow of $321.7M. Key risks: No defined technical setup (context-only state); high current ATR (5.6%) suggests elevated volatility; lack of named secular thesis limits conviction weight. Expected path: Management continues to execute on margin expansion and IAM adoption; price likely consolidates until a technical structure (coil) forms to validate the fundamental quality. Expected horizon: 3-6 months for structural setup formation.